Abstract
Nanotechnology has emerged as a promising strategy to enhance the therapeutic efficacy of anti-cancer drugs. Traditional cancer treatments often face limitations such as poor bioavailability, toxicity, and resistance. Nanotechnology provides innovative solutions by utilizing nanoscale materials to improve the delivery, effectiveness, and targeting of anti-cancer drugs. This article explores the role of nanotechnology in improving drug bioavailability, targeting specific tumor sites, minimizing side effects, and overcoming resistance mechanisms. The application of nanocarriers, such as liposomes, dendrimers, and nanoparticles, offers new avenues in precision cancer therapy. Furthermore, it discusses the clinical challenges and future directions for integrating nanotechnology into cancer treatment.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Dr. John Doe (Author)